**About the Editors**

**Ulrich-Axel Bommer**, Clinical Associate Professor at the School of Medicine, University of Wollongong, NSW, Australia. He received his Ph.D. degree from the Martin-Luther-University, Halle, Germany. As postdoctoral fellow at the Institute of Molecular Biology, East German Academy of Sciences, Berlin-Buch, he studied the structure and function of ribosomal complexes, which provided the basis for his Habilitation at the Martin-Luther-University, Halle. From 1991, he worked as a lecturer/senior lecturer at St. George's Hospital Medical School in London (UK), where he began research on TCTP. From 2006 to 2014, he was Associate Professor and a founding member at the Graduate School of Medicine, University of Wollongong, Australia.

**Toshiaki Kawakami**, Professor at the La Jolla Institute for Immunology, La Jolla, California, USA, received his M.D. and Ph.D. degrees from The University of Tokyo, Faculty of Medicine, Tokyo, Japan. He studied oncogenes as a postdoctoral fellow at the National Cancer Institute/NIH, Bethesda, Maryland, USA. After being Assistant Professor at Kyoto University, he joined the newly formed La Jolla Institute for Allergy and Immunology (currently La Jolla Institute for Immunology) as an assistant member (equivalent to Assistant Professor) in 1990 to start mast cell and allergy research.
